Rocket Pharmaceuticals In... (RCKT)
NASDAQ: RCKT
· Real-Time Price · USD
3.04
0.01 (0.33%)
At close: Aug 15, 2025, 3:59 PM
3.02
-0.68%
After-hours: Aug 15, 2025, 07:30 PM EDT
Rocket Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 32.82M | 49.81M | 163.63M | 65.6M | 38.61M | 35.28M | 55.9M | 225.66M | 45.08M | 64.58M | 140.52M | 196.67M | 187.55M | 130.55M | 232.69M | 245.64M | 264.61M | 252.54M |
Short-Term Investments | 238.68M | 268.35M | 208.7M | 170.06M | 240.22M | 295.04M | 317.27M | 211.51M | 261.96M | 266.5M | 215.88M | 109.86M | 133.82M | 216.04M | 156.05M | 175.81M | 162.22M | 213.81M |
Long-Term Investments | n/a | n/a | n/a | 1.36M | 1.36M | 1.36M | 34.32M | n/a | 1.36M | 28.96M | 43.28M | 1.35M | 1.34M | 1.34M | 1.34M | 1.33M | 1.33M | 1.46M |
Other Long-Term Assets | 1.88M | 1.88M | 1.89M | 503K | 481K | 533K | 1.37M | 3.29M | 1.9M | 1.8M | 1.95M | 1.81M | 1.8M | 1.8M | 1.8M | 1.79M | 1.79M | 1.92M |
Receivables | n/a | n/a | n/a | n/a | 8.1M | 8.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -900K | n/a | n/a | n/a | n/a |
Other Current Assets | 5.66M | 6.33M | 5.85M | 6.09M | 5.8M | n/a | 5.05M | 9.69M | 5.03M | 6.95M | 7.67M | 4.6M | 4.4M | n/a | 3.32M | 3.61M | 3.6M | 5.47M |
Total Current Assets | 277.15M | 324.49M | 378.18M | 241.75M | 292.73M | 345.16M | 378.22M | 446.87M | 312.07M | 338.03M | 364.06M | 311.13M | 325.77M | 353.85M | 392.06M | 425.07M | 430.43M | 471.82M |
Property-Plant & Equipment | 77.64M | 80.39M | 83.32M | 85.77M | 87.54M | 88.08M | 87.59M | 85.68M | 82.92M | 81.09M | 77.64M | 73.51M | 73.47M | 73.69M | 72.35M | 72.57M | 72.12M | 71.93M |
Goodwill & Intangibles | 64.3M | 64.3M | 64.3M | 64.3M | 64.3M | 64.3M | 64.3M | 64.3M | 64.88M | 64.88M | 64.88M | 30.82M | 30.82M | 30.82M | 30.82M | 30.82M | 30.82M | 30.82M |
Total Long-Term Assets | 143.82M | 146.57M | 149.52M | 151.93M | 153.69M | 154.28M | 188.12M | 151.9M | 149.71M | 176.72M | 187.75M | 106.13M | 106.08M | 106.3M | 104.96M | 105.17M | 104.73M | 104.66M |
Total Assets | 420.98M | 471.07M | 527.7M | 393.69M | 446.41M | 499.44M | 566.34M | 598.76M | 461.78M | 514.76M | 551.81M | 417.26M | 431.85M | 460.15M | 497.02M | 530.24M | 535.15M | 576.48M |
Account Payables | n/a | 2.94M | 1.63M | 2.77M | 3.06M | 2.75M | n/a | 1.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -2.75M | -1.77K | -1.85K | -1.11K | -1.67K | -37.43M | -1.88K | -21.84M | -965 | -482 | -651 | -669 | 597K |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 2.87M | 2.72M | 2.85M | 2.99M | 2.6M | n/a | 2.36M | 2.45M | 2.54M | n/a | 2.48M | 7.56M | 7.32M |
Other Current Liabilities | 8.05M | 4.13M | 10.32M | 34.36M | 24.38M | 802K | 20.01M | 17.56M | 21.75M | 21.22M | 26.06M | 20.07M | 15.79M | 15.41M | 14.48M | 15.12M | 11.71M | 24.05M |
Total Current Liabilities | 43.4M | 35.31M | 40.68M | 39.98M | 37.59M | 32.96M | 48.51M | 33.48M | 34.35M | 31.21M | 39.17M | 30.18M | 24.29M | 22.57M | 22.17M | 24.49M | 25.44M | 40.49M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 22.39M | 22.8M | n/a | 19.73M | 19.82M | 19.89M | n/a | 20M | 20.17M | 35.54M |
Other Long-Term Liabilities | 1.06M | 1.14M | 1.14M | 1.14M | 1.25M | 1.91M | 2.94M | 1.87M | -20.32M | -20.93M | 2.6M | -19.7M | -19.77M | -19.83M | 80K | -19.91M | -20.06M | 122K |
Total Long-Term Liabilities | 23.37M | 23.62M | 23.78M | 23.94M | 24.18M | 24.98M | 25.26M | 24.2M | 24.46M | 24.68M | 22.95M | 19.77M | 19.87M | 19.96M | 20.13M | 20.09M | 20.27M | 55.99M |
Total Liabilities | 66.77M | 58.93M | 64.47M | 63.92M | 61.78M | 57.94M | 73.77M | 57.68M | 58.81M | 55.88M | 62.12M | 49.95M | 44.16M | 42.53M | 42.3M | 44.58M | 45.72M | 96.48M |
Total Debt | 25.2M | 25.35M | 25.5M | 25.64M | 25.8M | 25.95M | 25.04M | 25.18M | 25.39M | 25.4M | 22.87M | 22.09M | 22.27M | 22.43M | 22.6M | 22.48M | 27.73M | 63.2M |
Common Stock | 1.08M | 1.07M | 1.06M | 911K | 910K | 906K | 903K | 901K | 805K | 804K | 791K | 678K | 658K | 645K | 645K | 644K | 634K | 619K |
Retained Earnings | -1.35B | -1.28B | -1.22B | -1.16B | -1.09B | -1.02B | -959.37M | -899.71M | -837.81M | -772.11M | -713.77M | -647.05M | -589.3M | -534.89M | -491.91M | -447.67M | -397.55M | -363.02M |
Comprehensive Income | -107K | -27K | 66K | 213K | -218K | -135K | 319K | -508K | -722K | -90K | -357K | -596K | -765K | -629K | -161K | -97K | -81K | -75K |
Shareholders Equity | 354.21M | 412.14M | 463.23M | 329.77M | 384.63M | 441.5M | 492.57M | 541.09M | 402.97M | 458.88M | 489.69M | 367.31M | 387.7M | 417.62M | 454.72M | 485.66M | 489.44M | 480M |
Total Investments | 238.68M | 268.35M | 208.7M | 170.06M | 241.58M | 296.4M | 351.59M | 211.51M | 261.96M | 28.96M | 259.15M | 109.86M | 133.82M | 216.04M | 156.05M | 175.81M | 162.22M | 213.81M |